Precigen (PGEN) News Today $1.83 -0.08 (-4.19%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$1.82 -0.01 (-0.27%) As of 07/11/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PGEN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Precigen (NASDAQ:PGEN) Upgraded at Wall Street ZenJuly 12 at 2:42 AM | marketbeat.comPrecigen (NASDAQ:PGEN) Sees Unusually-High Trading Volume - Should You Buy?July 9 at 2:12 PM | marketbeat.comIridian Asset Management LLC CT Sells 656,113 Shares of Precigen, Inc. (NASDAQ:PGEN)July 9 at 10:14 AM | marketbeat.comPrecigen (NASDAQ:PGEN) Shares Up 6.6% - Time to Buy?July 8, 2025 | marketbeat.comPrecigen: August Is Pivotal For This Biotech InnovatorJuly 7, 2025 | seekingalpha.comPrecigen, Inc. (PGEN) Latest Stock News & Headlines - Yahoo FinanceJuly 3, 2025 | finance.yahoo.comPrecigen (NASDAQ:PGEN) Stock Price Passes Above Fifty Day Moving Average - Time to Sell?July 3, 2025 | marketbeat.comPrecigen Announces Key Approvals at Annual MeetingJuly 2, 2025 | theglobeandmail.comPrecigen (NASDAQ:PGEN) Stock Passes Above 50-Day Moving Average - Should You Sell?June 24, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Earns Market Outperform Rating from JMP SecuritiesJune 12, 2025 | marketbeat.comPrecigen, Inc.'s (NASDAQ:PGEN) market cap touched US$455m last week, benefiting both private equity firms who own 33% as well as institutionsJune 12, 2025 | finance.yahoo.comCantor Fitzgerald Estimates Precigen FY2026 EarningsJune 11, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Sells 792,731 Shares of Precigen, Inc. (NASDAQ:PGEN)May 27, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Downgraded to "Sell" Rating by Wall Street ZenMay 26, 2025 | marketbeat.comFY2025 EPS Estimates for Precigen Cut by Cantor FitzgeraldMay 21, 2025 | marketbeat.comHC Wainwright Decreases Earnings Estimates for PrecigenMay 21, 2025 | marketbeat.comJ.P. Morgan Sticks to Its Sell Rating for Precigen (PGEN)May 20, 2025 | theglobeandmail.comPrecigen, Inc.: Precigen Reports First Quarter 2025 Financial Results and Business UpdatesMay 17, 2025 | finanznachrichten.deCantor Fitzgerald maintains Overweight on Precigen stockMay 17, 2025 | uk.investing.comPrecigen Reports First Quarter 2025 Financial Results and Business UpdatesMay 14, 2025 | prnewswire.comPrecigen (PGEN) Expected to Announce Earnings on TuesdayMay 8, 2025 | marketbeat.comPrecigen, Inc. (NASDAQ:PGEN) Shares Sold by Renaissance Technologies LLCMay 2, 2025 | marketbeat.comPrecigen and Recurrent Respiratory Papillomatosis Foundation to Host the 2025 International RRP Awareness Day on June 11thApril 16, 2025 | prnewswire.comIs Precigen (PGEN) The Hot Biotech Stock Under $5?March 27, 2025 | msn.comCantor Fitzgerald Comments on Precigen FY2025 EarningsMarch 24, 2025 | marketbeat.comHC Wainwright Has Negative Estimate for Precigen Q1 EarningsMarch 24, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Stock Price Up 6.9% - What's Next?March 22, 2025 | marketbeat.comFY2027 EPS Estimates for Precigen Decreased by HC WainwrightMarch 22, 2025 | marketbeat.comHC Wainwright Reiterates "Buy" Rating for Precigen (NASDAQ:PGEN)March 21, 2025 | marketbeat.comPrecigen options imply 20.1% move in share price post-earningsMarch 20, 2025 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Precigen (PGEN) and Edwards Lifesciences (EW)March 20, 2025 | markets.businessinsider.com4PGEN : Expert Outlook: Precigen Through The Eyes Of 4 AnalystsMarch 20, 2025 | benzinga.comPrecigen (NASDAQ:PGEN) Issues Quarterly Earnings Results, Beats Expectations By $0.02 EPSMarch 20, 2025 | marketbeat.comPrecigen, Inc.: Precigen Reports Full Year 2024 Financial Results and Business UpdatesMarch 20, 2025 | finanznachrichten.dePrecigen Reports Progress and Financial Results for 2024March 19, 2025 | tipranks.comPrecigen, Inc. (PGEN) Q4 2024 Earnings Call TranscriptMarch 19, 2025 | seekingalpha.comPrecigen Reports Full Year 2024 Financial Results and Business UpdatesMarch 19, 2025 | prnewswire.comPrecigen (NASDAQ:PGEN) Shares Down 4.2% - Here's WhyMarch 18, 2025 | marketbeat.comPrecigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19thMarch 13, 2025 | prnewswire.comPrecigen, Inc. (NASDAQ:PGEN) Given Consensus Recommendation of "Moderate Buy" by AnalystsMarch 11, 2025 | marketbeat.comPrecigen (PGEN) Projected to Post Earnings on TuesdayMarch 11, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Shares Up 7.7% - Time to Buy?February 28, 2025 | marketbeat.comPrecigen: UltraCAR-T Development Brings Another Side Of Pipeline AdvancementFebruary 28, 2025 | seekingalpha.comPrecigen shares surge on FDA priority review for PRGN-2012February 25, 2025 | in.investing.comPrecigen (NASDAQ:PGEN) Shares Gap Up - What's Next?February 25, 2025 | marketbeat.comPrecigen’s BLA for PRGN-2012 in papillomatosis granted priority review by FDAFebruary 25, 2025 | markets.businessinsider.comFDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025February 25, 2025 | prnewswire.comPrecigen (NASDAQ:PGEN) Hits New 1-Year High - Here's WhyFebruary 20, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Trading 8.4% Higher - Here's What HappenedFebruary 19, 2025 | marketbeat.comAnalysts Set Precigen, Inc. (NASDAQ:PGEN) Price Target at $7.00February 17, 2025 | marketbeat.com Get Precigen News Delivered to You Automatically Sign up to receive the latest news and ratings for PGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address PGEN Media Mentions By Week PGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PGEN News Sentiment▼1.401.00▲Average Medical News Sentiment PGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PGEN Articles This Week▼62▲PGEN Articles Average Week Get Precigen News Delivered to You Automatically Sign up to receive the latest news and ratings for PGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BLTE News Today IDYA News Today HRMY News Today IRON News Today CNTA News Today APGE News Today ADPT News Today SRPT News Today SPRY News Today TARS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PGEN) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precigen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precigen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
